ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Robert D. Lasley
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lasley, R. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lasley, R. D.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2001;72:563-564
© 2001 The Society of Thoracic Surgeons

Invited commentary

Robert D. Lasley, PhDa

a Department of Surgery, University of Kentucky, College of Medicine, Chandler Medical Center, 800 Rose St, Room MN 276, Lexington, KY 40536-0298, USA

e-mail: rlasley@pop.uky.edu

The study by Stadler and colleagues addresses several timely aspects of myocardial ischemia-reperfusion injury and its amelioration by exogenous and endogenous agents. The cardioprotective effects of adenosine and ischemic preconditioning have been reported by numerous laboratories, but this is one of the few studies to combine these two interventions. The observation that adenosine enhanced ischemic preconditioning provided a greater degree of infarct reduction than either therapy alone suggests that these two interventions may exert their beneficial effects by different mechanisms. This hypothesis is . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.